Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-05-10 4:37 pm Sale |
2023-05-08 | 13D | Acorda Therapeutics, Inc. ACOR |
Davidson Kempner Capital Management LP | 55,144 4.530% |
-35,009 (-38.83%) |
Filing History |
| 2023-03-10 4:15 pm Sale |
2023-03-08 | 13D | Acorda Therapeutics, Inc. ACOR |
Davidson Kempner Capital Management LP | 90,154 7.410% |
-13,985 (-13.43%) |
Filing History |
| 2023-02-14 4:52 pm Sale |
2022-12-31 | 13G | Acorda Therapeutics, Inc. ACOR |
CANYON CAPITAL ADVISORS LLC | 0 0.000% |
-32,452 (Position Closed) |
Filing History |
| 2023-02-13 12:35 pm Purchase |
2022-12-30 | 13G | Acorda Therapeutics, Inc. ACOR |
Renaissance Technologies LLC | 43,445 3.570% |
7,737 (+21.67%) |
Filing History |
| 2023-01-23 4:30 pm Sale |
2023-01-19 | 13D | Acorda Therapeutics, Inc. ACOR |
Davidson Kempner Capital Management LP | 104,138 8.560% |
-16,027 (-13.34%) |
Filing History |
| 2022-06-10 4:24 pm Unchanged |
2022-06-02 | 13G | Acorda Therapeutics, Inc. ACOR |
SOROS FUND MANAGEMENT LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-06-10 4:15 pm Purchase |
2022-06-02 | 13D | Acorda Therapeutics, Inc. ACOR |
Davidson Kempner Capital Management LP | 120,165 9.900% |
120,165 (New Position) |
Filing History |
| 2022-02-14 4:56 pm Purchase |
2021-12-31 | 13G | Acorda Therapeutics, Inc. ACOR |
CANYON CAPITAL ADVISORS LLC | 32,452 5.790% |
22,633 (+230.52%) |
Filing History |
| 2022-02-14 4:33 pm Purchase |
2021-12-31 | 13G | Acorda Therapeutics, Inc. ACOR |
Point72 Asset Management, L.P. | 23,214 4.100% |
23,214 (New Position) |
Filing History |
| 2022-02-14 10:16 am Unchanged |
2021-12-31 | 13G | Acorda Therapeutics, Inc. ACOR |
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-11 2:20 pm Purchase |
2021-12-31 | 13G | Acorda Therapeutics, Inc. ACOR |
Renaissance Technologies LLC | 35,708 6.380% |
35,708 (New Position) |
Filing History |
| 2021-04-28 6:13 pm Sale |
2020-12-31 | 13G | Acorda Therapeutics, Inc. ACOR |
CANYON CAPITAL ADVISORS LLC | 9,818 1.820% |
-65,179 (-86.91%) |
Filing History |
| 2021-02-16 4:16 pm Purchase |
2020-12-31 | 13G | Acorda Therapeutics, Inc. ACOR |
CANYON CAPITAL ADVISORS LLC | 74,997 13.910% |
74,997 (New Position) |
Filing History |
| 2021-02-16 3:55 pm Sale |
2020-12-31 | 13G | Acorda Therapeutics, Inc. ACOR |
DIMENSIONAL FUND ADVISORS INC | 0 0.000% |
-24,879 (Position Closed) |
Filing History |
| 2021-02-16 3:10 pm Purchase |
2020-12-31 | 13G | Acorda Therapeutics, Inc. ACOR |
Point72 Asset Management, L.P. | 45,168 1.900% |
5,985 (+15.28%) |
Filing History |
| 2021-02-16 10:41 am Purchase |
2020-12-31 | 13G | Acorda Therapeutics, Inc. ACOR |
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 266,162 9.990% |
266,162 (New Position) |
Filing History |
| 2021-02-12 07:46 am Unchanged |
2020-12-31 | 13G | Acorda Therapeutics, Inc. ACOR |
SYMPHONY ASSET MANAGEMENT LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-02-11 10:24 am Purchase |
2020-12-31 | 13G | Acorda Therapeutics, Inc. ACOR |
Renaissance Technologies LLC | 204,264 8.520% |
172,121 (+535.47%) |
Filing History |
| 2021-02-10 2:49 pm Sale |
2021-01-31 | 13G | Acorda Therapeutics, Inc. ACOR |
FEDERATED HERMES INC. FHI |
5,331 1.330% |
-26,728 (-83.37%) |
Filing History |
| 2021-02-10 12:46 pm Purchase |
2020-12-31 | 13G | Acorda Therapeutics, Inc. ACOR |
FEDERATED HERMES INC. FHI |
32,059 8.020% |
32,059 (New Position) |
Filing History |